Equities

AtriCure Inc

ATRC:NMQ

AtriCure Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)35.68
  • Today's Change-0.35 / -0.97%
  • Shares traded1.49k
  • 1 Year change-14.44%
  • Beta1.4016
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments137121119
Total Receivables, Net534333
Total Inventory684639
Prepaid expenses8.565.485.00
Other current assets, total------
Total current assets266215196
Property, plant & equipment, net474336
Goodwill, net235235235
Intangibles, net643943
Long term investments052104
Note receivable - long term------
Other long term assets2.161.990.96
Total assets614585615
LIABILITIES
Accounts payable272019
Accrued expenses463436
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.094.330.90
Other current liabilities, total----1.45
Total current liabilities755856
Total long term debt696670
Total debt707071
Deferred income tax------
Minority interest------
Other liabilities, total4.544.325.29
Total liabilities148129132
SHAREHOLDERS EQUITY
Common stock0.050.050.05
Additional paid-in capital824787765
Retained earnings (accumulated deficit)(357)(327)(280)
Treasury stock - common------
Unrealized gain (loss)(0.8)(3.7)(0.89)
Other equity, total(0.19)(0.4)(0.06)
Total equity466457484
Total liabilities & shareholders' equity614585615
Total common shares outstanding484746
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.